EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Change in Motor and Nonmotor Symptoms Severity in a “Real-Life” Cohort of Subjects with Parkinson’s Disease

Adib Jorge de Saráchaga, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, Humberto Calderón-Fajardo, Mayela Rodríguez-Violante

Neuroscience Journal · 2015

DOI: 10.1155/2015/368989 ↗
AbstractBibliografische Angaben

Abstract

Background . Parkinson’s disease (PD) is a chronic and progressive disorder. Rates of change in motor symptoms have been more studied compared to nonmotor symptoms. The objective was to describe these changes in a real-life cohort of subjects with PD. Methods . A cohort study was carried out from 2011 to 2013. Consecutive patients with PD were recruited from a movement disorders clinic. MDS-UPDRS, PDQ-8, and NMSS were applied to all subjects at an initial evaluation and a subsequent visit ( 21 ± 3 months). Disease severity was categorized using a recent classification of MDS-UPDRS severity. Results . The MDS-UPDRS Part III showed a significant decrease of 7.2 ± 2.31 points ( p = 0.001 ) between evaluations. A mean increase of 0.9 ± 0.6 points ( p = 0.015 ) in the MDS-UPDRS Part IV was observed. An increase of 14.3 ± 11.4 points ( p = 0.043 ) in the NMSS total score was found; when assessed individually, the difference was statistically significant only for the perceptual problems/hallucinations item. Quality of life remained unchanged. Conclusion . Motor improvement was observed accompanied by an increase in motor complications possibly as a result of treatment optimization. Nonmotor symptoms worsened as a whole. The overall effect in the quality of life was negligible.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →